As discussed in Note 1, the Company made corrections to the consolidated financial statements for periods ended December 31, 2022, January 1, 2022, and the quarterly periods of 2023. A summary of the corrections related to prior periods presented are as follows (tables may not foot or cross foot due to rounding):


Condensed Consolidated Statement of Operations
July 15, 2023
	Twelve Weeks Ended						Twenty-Eight Weeks Ended
	As Previously Reported		Adjustments		As Corrected		As Previously Reported		Adjustments		As Corrected
Cost of sales	$	1,537,997	$	7,614	$	1,545,611	$	3,484,927	$	16,350	$	3,501,277
Gross profit	1,148,069		(7,614)		1,140,455		2,618,732		(16,350)		2,602,382
Selling, general and administrative expenses	1,013,701		794		1,014,495		2,394,365		(15,881)		2,378,484
Operating income	134,368		(8,408)		125,960		224,367		(469)		223,898





Income before provision for income taxes	115,183		(8,408)		106,775		174,789		(469)		174,320
Provision for income taxes	29,821		(1,623)		28,198		46,776		644		47,420
Net income	$	85,362	$	(6,785)	$	78,577	$	128,013	$	(1,113)	$	126,900

Basic earnings per share	$	1.44	$	(0.12)	$	1.32	$	2.16	$	(0.02)	$	2.14


Diluted earnings per common share	$	1.43	$	(0.11)	$	1.32	$	2.15	$	(0.02)	$	2.13


Condensed Consolidated Statement of Comprehensive Income
July 15, 2023
	Twelve Weeks Ended						Twenty-Eight Weeks Ended
	As Previously Reported		Adjustments		As Corrected		As Previously Reported		Adjustments		As Corrected
Net income	$	85,362	$	(6,785)	$	78,577	$	128,013	$	(1,113)	$	126,900
Currency translation adjustments	7,569		(307)		7,262		8,160		(331)		7,829
Total other comprehensive loss	7,531		(307)		7,224		8,319		(331)		7,988
Comprehensive income	$	92,893	$	(7,092)	$	85,801	$	136,332	$	(1,444)	$	134,888


Condensed Consolidated Statements of Changes in Stockholders’ Equity
Twelve Weeks Ended July 15, 2023
	Accumulated Other Comprehensive Loss		Retained Earnings		Total Stockholders' Equity
Twelve Weeks Ended As Previously Reported
Balance at April 22, 2023	$	(44,355)	$	4,697,697	$	2,636,161
Net income	—		85,362		85,362
Total other comprehensive income	7,531		—		7,531
Balance at July 15, 2023	$	(36,824)	$	4,767,168	$	2,723,187
Adjustments
Balance at April 22, 2023	$	424	$	(73,865)	$	(73,441)
Net income	—		(6,785)		(6,785)
Total other comprehensive income	(307)		—		(307)
Balance at July 15, 2023	$	117	$	(80,650)	$	(80,533)
As Corrected
Balance at April 22, 2023	$	(43,931)	$	4,623,832	$	2,562,720
Net income	—		78,577		78,577
Total other comprehensive income	7,224		—		7,224
Balance at July 15, 2023	$	(36,707)	$	4,686,518	$	2,642,654


Condensed Consolidated Statements of Changes in Stockholders’ Equity
Twenty-Eight Weeks Ended July 15, 2023
	Accumulated Other Comprehensive Loss		Retained Earnings		Total Stockholders' Equity
Twenty-Eight Weeks Ended As Previously Reported
Balance at December 31, 2022	$	(45,143)	$	4,744,624	$	2,678,281
Net income	—		128,013		128,013
Total other comprehensive income	8,319		—		8,319
Balance at July 15, 2023	$	(36,824)	$	4,767,168	$	2,723,187
Adjustments
Balance at December 31, 2022	$	448	$	(79,537)	$	(79,089)
Net income	—		(1,113)		(1,113)
Total other comprehensive income	(331)		—		(331)
Balance at July 15, 2023	$	117	$	(80,650)	$	(80,533)
As Corrected
Balance at December 31, 2022	$	(44,695)	$	4,665,087	$	2,599,192
Net income	—		126,900		126,900
Total other comprehensive income	7,988		—		7,988
Balance at July 15, 2023	$	(36,707)	$	4,686,518	$	2,642,654


Condensed Consolidated Statement of Cash Flows
Twenty-Eight Weeks Ended July 15, 2023
	As Previously Reported		Adjustments		As Corrected
Net income	$	128,013	$	(1,113)	$	126,900
Provision for deferred income taxes	16,249		5,248		21,497
Other, net	1,170		458		1,628
Net change in:
Receivables, net	(93,539)		(3,483)		(97,022)
Inventories, net	(145,148)		(3,770)		(148,918)
Accounts payable	(346,808)		27,023		(319,785)
Accrued expenses	120,888		(2,107)		118,781
Other assets and liabilities, net	(36,008)		(24,828)		(60,836)
Net cash used in operating activities	(164,559)		(2,572)		(167,131)
Other, net (1)	(4,073)		(458)		(4,531)
Net cash provided by financing activities	314,403		(458)		313,945
Effect of exchange rate changes on cash	1,280		(331)		949
Net increase in cash and cash equivalents	7,782		(3,361)		4,421
Cash and cash equivalents, beginning of period	269,282		1,523		270,805
Cash and cash equivalents, end of period	$	277,064	$	(1,838)	$	275,226